Viewing Study NCT06259058

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2026-01-22 @ 11:51 AM
Study NCT ID: NCT06259058
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-15
First Post: 2024-02-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None borderline resectable View
None NALIRIFOX View
None stereotactic body radiation therapy View